{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:03:00Z","timestamp":1782205380889,"version":"3.54.5"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T00:00:00Z","timestamp":1468281600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00296-016-3530-3","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T06:49:28Z","timestamp":1468306168000},"page":"85-95","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["A critical view on cardiovascular risk in systemic sclerosis"],"prefix":"10.1007","volume":"37","author":[{"given":"Antonios","family":"Psarras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios","family":"Soulaidopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Garyfallos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0364-1642","authenticated-orcid":false,"given":"Theodoros","family":"Dimitroulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,12]]},"reference":[{"key":"3530_CR1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/BOR.0b013e32834ff2e8","volume":"24","author":"J Barnes","year":"2012","unstructured":"Barnes J, Mayes MD (2012) Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers. Curr Opin Rheumatol 24:165\u2013170","journal-title":"Curr Opin Rheumatol"},{"key":"3530_CR2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.semarthrit.2007.05.003","volume":"37","author":"H Chifflot","year":"2008","unstructured":"Chifflot H et al (2008) Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 37:223\u2013235","journal-title":"Semin Arthritis Rheum"},{"key":"3530_CR3","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A et al (2009) Scleroderma. N Engl J Med 360:1989\u20132003","journal-title":"N Engl J Med"},{"key":"3530_CR4","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2174\/138161212799504704","volume":"18","author":"T Dimitroulas","year":"2012","unstructured":"Dimitroulas T, Giannakoulas G, Karvounis H, Settas L, Kitas GD (2012) Systemic sclerosis-related pulmonary hypertension: unique characteristics and future treatment targets. Curr Pharm Des 18:1457\u20131464","journal-title":"Curr Pharm Des"},{"key":"3530_CR5","first-page":"8","volume":"3","author":"F Cannarile","year":"2015","unstructured":"Cannarile F et al (2015) Cardiovascular disease in systemic sclerosis. Ann Transl Med 3:8","journal-title":"Ann Transl Med"},{"issue":"11","key":"3530_CR6","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409\u20131417","journal-title":"Rheumatol Int"},{"key":"3530_CR7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ncprheum0092","volume":"2","author":"Y Sherer","year":"2006","unstructured":"Sherer Y, Shoenfeld Y (2006) Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2:99\u2013106","journal-title":"Nat Clin Pract Rheumatol"},{"key":"3530_CR8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/ard.2010.142133","volume":"70","author":"GD Kitas","year":"2011","unstructured":"Kitas GD, Gabriel SE (2011) Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis 70:8\u201314","journal-title":"Ann Rheum Dis"},{"key":"3530_CR9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.autrev.2013.03.013","volume":"12","author":"I Hollan","year":"2013","unstructured":"Hollan I et al (2013) Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev 12:1004\u20131015","journal-title":"Autoimmun Rev"},{"key":"3530_CR10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrrheum.2015.112","volume":"11","author":"MT Nurmohamed","year":"2015","unstructured":"Nurmohamed MT, Heslinga M, Kitas GD (2015) Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol 11:693\u2013704","journal-title":"Nat Rev Rheumatol"},{"key":"3530_CR11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/ard.2006.059980","volume":"67","author":"A Gonzalez","year":"2008","unstructured":"Gonzalez A, Maradit Kremers H, Crowson CS, Ballman KV, Roger VL, Jacobsen SJ et al (2008) Cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis 67:64\u201369","journal-title":"Ann Rheum Dis"},{"key":"3530_CR12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/1759720X16643340","volume":"8","author":"T Zegos","year":"2016","unstructured":"Zegos T, Kitas G, Dimitroulas T (2016) Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps. Ther Adv Musculoskelet Dis 8:86\u2013101","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"3530_CR13","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/eurheartj\/ehw018","volume":"37","author":"A Faccini","year":"2016","unstructured":"Faccini A, Kaski JC, Camici PG (2016) Coronary microvascular dysfunction in chronic nflammatory rheumatoid diseases. Eur Heart J 37:1799\u20131806","journal-title":"Eur Heart J"},{"key":"3530_CR14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/1756-185X.12134","volume":"16","author":"A Sharma","year":"2013","unstructured":"Sharma A, Gopalakrishnan D, Kumar R, Vijayvergiya R, Dogra S (2013) Metabolic syndrome in psoriatic arthritis patients: a cross-sectional study. Int J Rheum Dis 16:667\u2013673","journal-title":"Int J Rheum Dis"},{"key":"3530_CR15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/ard.62.7.607","volume":"62","author":"G Medina","year":"2003","unstructured":"Medina G et al (2003) Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome. Ann Rheum Dis 62:607\u2013610","journal-title":"Ann Rheum Dis"},{"key":"3530_CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/rheumatology\/kep366","volume":"49","author":"SL Westlake","year":"2010","unstructured":"Westlake SL, Colebatch AN, Baird J, Kiely P, Quinn M, Choy E et al (2010) The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology (Oxford) 49:295\u2013307","journal-title":"Rheumatology (Oxford)"},{"key":"3530_CR17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2474-13-127","volume":"13","author":"A Sandoo","year":"2012","unstructured":"Sandoo A, van Zanten JJ, Toms TE, Carroll D, Kitas GD (2012) Anti-TNF\u03b1 therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a pilot study. BMC Musculoskelet Disord 13:127","journal-title":"BMC Musculoskelet Disord"},{"key":"3530_CR18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/ard.2004.026534","volume":"64","author":"DN Kiortsis","year":"2005","unstructured":"Kiortsis DN, Mavridis AK, Vasakos S, Nikas SN, Drosos AA (2005) Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis 64:765\u2013766","journal-title":"Ann Rheum Dis"},{"key":"3530_CR19","doi-asserted-by":"crossref","first-page":"R160","DOI":"10.1186\/ar3900","volume":"14","author":"A Stavropoulos-Kalinoglou","year":"2012","unstructured":"Stavropoulos-Kalinoglou A, Metsios GS, Panoulas VF, Nightingale P, Koutedakis Y, Kitas GD (2012) Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis. Arthritis Res Ther 14:R160","journal-title":"Arthritis Res Ther"},{"key":"3530_CR20","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2174\/138161212799504759","volume":"18","author":"AY Gasparyan","year":"2012","unstructured":"Gasparyan AY, Ayvazyan L, Cocco G, Kitas GD (2012) Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research. Curr Pharm Des 18:1543\u20131555","journal-title":"Curr Pharm Des"},{"key":"3530_CR21","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/ard.2010.145839","volume":"70","author":"MT Nurmohamed","year":"2011","unstructured":"Nurmohamed MT, Kitas G (2011) Cardiovascular risk in rheumatoid arthritis and diabetes: how does it compare and when does it start? Annals of the rheumatic diseases. Ann Rheum Dis 70:881\u2013883","journal-title":"Ann Rheum Dis"},{"key":"3530_CR22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/187152810793358750","volume":"9","author":"T Dimitroulas","year":"2010","unstructured":"Dimitroulas T, Sarafidis P, Roma V, Karagiannopoulou G, Kapoulas S, Dimitroula H et al (2010) Scleroderma renal crisis accompanied by new-onsetpulmonary arterial hypertension: an acute systemic endothelial injury? Casereport and literature. Inflamm Allergy Drug Targets 9:313\u2013318","journal-title":"Inflamm Allergy Drug Targets"},{"key":"3530_CR23","doi-asserted-by":"crossref","unstructured":"Sime\u00f3n-Aznar CP, Fonollosa-Pl\u00e1 V, Tolosa-Vilella C, Espinosa-Garriga G, Campillo-Grau M, Ramos-Casals M et al Spanish Scleroderma Study Group (SSSG); Autoimmune Diseases Study Group (GEAS); Spanish Society of Internal Medicine (SEMI) (2015) Registry of the Spanish Network for systemic sclerosis: survival, prognostic factors, and causes of death. Medicine (Baltimore) 94:e1728","DOI":"10.1097\/MD.0000000000001728"},{"key":"3530_CR24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.autrev.2010.09.014","volume":"10","author":"U Nussinovitch","year":"2011","unstructured":"Nussinovitch U, Shoenfeld Y (2011) Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality. Autoimmun Rev 10:259\u2013266","journal-title":"Autoimmun Rev"},{"key":"3530_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4081\/rr.2014.5558","volume":"6","author":"A Psarras","year":"2014","unstructured":"Psarras A et al (2014) Giant cell arteritis and systemic sclerosis: a rare overlap syndrome. Rheumatol Rep 6:1","journal-title":"Rheumatol Rep"},{"key":"3530_CR26","first-page":"126","volume":"9","author":"SL Hupp","year":"1989","unstructured":"Hupp SL (1989) Giant cell arteritis associated with progressive systemic sclerosis. J Clin Neuroophthalmol 9:126\u2013130","journal-title":"J Clin Neuroophthalmol"},{"key":"3530_CR27","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/rheumatology\/37.7.750","volume":"37","author":"S Jacobsen","year":"1998","unstructured":"Jacobsen S et al (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37:750\u2013755","journal-title":"Br J Rheumatol"},{"key":"3530_CR28","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/ard.57.11.682","volume":"57","author":"R Hesselstrand","year":"1998","unstructured":"Hesselstrand R et al (1998) Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 57:682\u2013686","journal-title":"Ann Rheum Dis"},{"key":"3530_CR29","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69:1809\u20131815","journal-title":"Ann Rheum Dis"},{"key":"3530_CR30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/acr.22152","volume":"66","author":"AJ Dave","year":"2014","unstructured":"Dave AJ et al (2014) Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis. Arthritis Care Res (Hoboken) 66:323\u2013327","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3530_CR31","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/annrheumdis-2012-202007","volume":"72","author":"A Man","year":"2013","unstructured":"Man A et al (2013) The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study. Ann Rheum Dis 72:1188\u20131193","journal-title":"Ann Rheum Dis"},{"key":"3530_CR32","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1136\/annrheumdis-2011-201176","volume":"71","author":"GS Ngian","year":"2012","unstructured":"Ngian GS et al (2012) Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis. Ann Rheum Dis 71:1980\u20131983","journal-title":"Ann Rheum Dis"},{"key":"3530_CR33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/ar3445","volume":"13","author":"GS Ngian","year":"2011","unstructured":"Ngian GS et al (2011) Cardiovascular disease in systemic sclerosis\u2013an emerging association? Arthritis Res Ther 13:237","journal-title":"Arthritis Res Ther"},{"key":"3530_CR34","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.amjmed.2015.10.037","volume":"129","author":"JA Avi\u00f1a-Zubieta","year":"2016","unstructured":"Avi\u00f1a-Zubieta JA, Man A, Yurkovich M, Huang K, Sayre EC, Choi HK (2016) Early cardiovascular disease after the diagnosis of systemic sclerosis. Am J Med 129:324\u2013331","journal-title":"Am J Med"},{"key":"3530_CR35","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","volume":"46","author":"WA D\u2019Angelo","year":"1969","unstructured":"D\u2019Angelo WA et al (1969) Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 46:428\u2013440","journal-title":"Am J Med"},{"key":"3530_CR36","first-page":"469","volume":"22","author":"P Youssef","year":"1995","unstructured":"Youssef P et al (1995) Limited scleroderma is associated with increased prevalence of macrovascular disease. J Rheumatol 22:469\u2013472","journal-title":"J Rheumatol"},{"key":"3530_CR37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/ard.2008.096255","volume":"69","author":"A Komocsi","year":"2010","unstructured":"Komocsi A et al (2010) Overlap of coronary disease and pulmonary arterial hypertension in systemic sclerosis. Ann Rheum Dis 69:202\u2013205","journal-title":"Ann Rheum Dis"},{"key":"3530_CR38","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10067-006-0211-8","volume":"26","author":"CT Derk","year":"2007","unstructured":"Derk CT, Jimenez SA (2007) Acute myocardial infarction in systemic sclerosis patients: a case series. Clin Rheumatol 26:965\u2013968","journal-title":"Clin Rheumatol"},{"key":"3530_CR39","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/art.23540","volume":"59","author":"V Khurma","year":"2008","unstructured":"Khurma V et al (2008) A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls. Arthritis Rheum 59:591\u2013597","journal-title":"Arthritis Rheum"},{"key":"3530_CR40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10067-005-0073-5","volume":"25","author":"G Tarek","year":"2006","unstructured":"Tarek G et al (2006) Coronary angiographic findings in asymptomatic systemic sclerosis. Clin Rheumatol 25:487\u2013490","journal-title":"Clin Rheumatol"},{"key":"3530_CR41","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-8703(98)70137-1","volume":"136","author":"J Lekakis","year":"1998","unstructured":"Lekakis J et al (1998) Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud\u2019s phenomenon. Am Heart J 136:905\u2013912","journal-title":"Am Heart J"},{"key":"3530_CR42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1196\/annals.1422.028","volume":"1108","author":"Y Sherer","year":"2007","unstructured":"Sherer Y et al (2007) Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis. Ann N Y Acad Sci 1108:259\u2013267","journal-title":"Ann N Y Acad Sci"},{"key":"3530_CR43","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/rheumatology\/kel433","volume":"46","author":"F Bartoli","year":"2007","unstructured":"Bartoli F et al (2007) Angiotensin-converting enzyme I\/D polymorphism and macrovascular disease in systemic sclerosis. Rheumatology (Oxford) 46:772\u2013775","journal-title":"Rheumatology (Oxford)"},{"key":"3530_CR44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1196\/annals.1422.030","volume":"1108","author":"F Bartoli","year":"2007","unstructured":"Bartoli F et al (2007) Flow-mediated vasodilation and carotid intima-media thickness in systemic sclerosis. Ann N Y Acad Sci 1108:283\u2013290","journal-title":"Ann N Y Acad Sci"},{"key":"3530_CR45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/rheumatology\/kel076","volume":"46","author":"O Kaloudi","year":"2007","unstructured":"Kaloudi O et al (2007) Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. Rheumatology (Oxford) 46:412\u2013416","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 3","key":"3530_CR46","first-page":"692","volume":"69","author":"U Kumar","year":"2010","unstructured":"Kumar U, Verma N, Kumar AK, Hari S, Yadav R, Sreenivas V et al (2010) Endothelial dysfunction in Indian patients with systemic sclerosis[abstract]. Ann Rheum Dis 69(Suppl 3):692","journal-title":"Ann Rheum Dis"},{"key":"3530_CR47","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3109\/03009741003605648","volume":"39","author":"N Tsifetaki","year":"2010","unstructured":"Tsifetaki N et al (2010) Subclinical atherosclerosis in scleroderma patients. Scand J Rheumatol 39:326\u2013329","journal-title":"Scand J Rheumatol"},{"key":"3530_CR48","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/ar2408","volume":"10","author":"ME Hettema","year":"2008","unstructured":"Hettema ME, Zhang D, de Leeuw K, Stienstra Y, Smit AJ, Kallenberg CG, Bootsma H (2008) Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors. Arthritis Res Ther 10:R49","journal-title":"Arthritis Res Ther"},{"key":"3530_CR49","first-page":"1576","volume":"35","author":"M Roustit","year":"2008","unstructured":"Roustit M et al (2008) Discrepancy between simultaneous digital skin microvascular and brachial artery macrovascular post-occlusive hyperemia in systemic sclerosis. J Rheumatol 35:1576\u20131583","journal-title":"J Rheumatol"},{"key":"3530_CR50","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/0003319710387918","volume":"62","author":"MC Piccione","year":"2011","unstructured":"Piccione MC et al (2011) Early identification of vascular damage in patients with systemic sclerosis. Angiology 62:338\u2013343","journal-title":"Angiology"},{"key":"3530_CR51","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/acr.20306","volume":"63","author":"J Liu","year":"2011","unstructured":"Liu J et al (2011) Preferential macrovasculopathy in systemic sclerosis detected by regional pulse wave velocity from wave intensity analysis: comparisons of local and regional arterial stiffness parameters in cases and controls. Arthritis Care Res (Hoboken) 63:579\u2013587","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3530_CR52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/ard.59.1.39","volume":"59","author":"M Ho","year":"2000","unstructured":"Ho M et al (2000) Macrovascular disease and systemic sclerosis. Ann Rheum Dis 59:39\u201343","journal-title":"Ann Rheum Dis"},{"key":"3530_CR53","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/rheumatology\/ket411","volume":"53","author":"E Schiopu","year":"2014","unstructured":"Schiopu E et al (2014) Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound. Rheumatology (Oxford) 53:704\u2013713","journal-title":"Rheumatology (Oxford)"},{"key":"3530_CR54","doi-asserted-by":"crossref","unstructured":"Ozen G, Inanc N, Unal AU, Korkmaz F, Sunbul M, Ozmen M et al (2016) Subclinical Atherosclerosis in systemic sclerosis: not less frequent than rheumatoid arthritis and not detected with cardiovascular risk indices. Arthritis Care Res (Hoboken) 2016 Feb 11 [Epub ahead of print]","DOI":"10.1002\/acr.22852"},{"key":"3530_CR55","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/rheumatology\/kel426","volume":"46","author":"G Szucs","year":"2007","unstructured":"Szucs G et al (2007) Endothelial dysfunction precedes atherosclerosis in systemic sclerosis\u2013relevance for prevention of vascular complications. Rheumatology (Oxford) 46:759\u2013762","journal-title":"Rheumatology (Oxford)"},{"key":"3530_CR56","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3899\/jrheum.091116","volume":"37","author":"D Rollando","year":"2010","unstructured":"Rollando D et al (2010) Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with nailfold microvascular impairment. J Rheumatol 37:1168\u20131173","journal-title":"J Rheumatol"},{"key":"3530_CR57","first-page":"295","volume":"5","author":"M Stucker","year":"2000","unstructured":"Stucker M et al (2000) Macroangiopathy of the upper extremities in progressive systemic sclerosis. Eur J Med Res 5:295\u2013302","journal-title":"Eur J Med Res"},{"key":"3530_CR58","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/art.1780310311","volume":"31","author":"DC Trostle","year":"1988","unstructured":"Trostle DC et al (1988) Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study. Arthritis Rheum 31:393\u2013400","journal-title":"Arthritis Rheum"},{"key":"3530_CR59","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.57.8.476","volume":"57","author":"L Stafford","year":"1998","unstructured":"Stafford L et al (1998) Distribution of macrovascular disease in scleroderma. Ann Rheum Dis 57:476\u2013479","journal-title":"Ann Rheum Dis"},{"key":"3530_CR60","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2174\/13816128113199990555","volume":"20","author":"T Dimitroulas","year":"2014","unstructured":"Dimitroulas T, Giannakoulas G, Karvounis H, Garyfallos A, Settas L, Kitas GD (2014) Micro- and macro-vascular treatment targets in scleroderma heart disease. Curr Pharm 20:536\u2013544","journal-title":"Curr Pharm"},{"key":"3530_CR61","first-page":"199","volume":"21","author":"NA Zakopoulos","year":"2003","unstructured":"Zakopoulos NA et al (2003) Systemic sclerosis is not associated with clinical or ambulatory blood pressure. Clin Exp Rheumatol 21:199\u2013204","journal-title":"Clin Exp Rheumatol"},{"issue":"2 Suppl 71","key":"3530_CR62","first-page":"S76","volume":"30","author":"Y Zeng","year":"2012","unstructured":"Zeng Y et al (2012) Macrovascular involvement in systemic sclerosis: evidence of correlation with disease activity. Clin Exp Rheumatol 30(2 Suppl 71):S76\u2013S80","journal-title":"Clin Exp Rheumatol"},{"issue":"1\u20132","key":"3530_CR63","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cca.2005.07.015","volume":"364","author":"G Lippi","year":"2006","unstructured":"Lippi G et al (2006) Lipoprotein[a] and the lipid profile in patients with systemic sclerosis. Clin ChimActa 364(1\u20132):345\u2013348","journal-title":"Clin ChimActa"},{"key":"3530_CR64","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00296-004-0580-8","volume":"25","author":"EF Borba","year":"2005","unstructured":"Borba EF et al (2005) Lipoprotein profile in limited systemic sclerosis. Rheumatol Int 25:379\u2013383","journal-title":"Rheumatol Int"},{"issue":"Suppl 2","key":"3530_CR65","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar2186","volume":"9","author":"DJ Abraham","year":"2007","unstructured":"Abraham DJ, Distler O (2007) How does endothelial cell injury start? The role of endothelin in systemic sclerosis. Arthritis Res Ther 9(Suppl 2):S2","journal-title":"Arthritis Res Ther"},{"key":"3530_CR66","doi-asserted-by":"crossref","unstructured":"Abraham DJ, Krieg T, Distler O (2009) Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxford)48(Suppl 3):iii3-7","DOI":"10.1093\/rheumatology\/ken481"},{"key":"3530_CR67","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1378\/chest.120.4.1301","volume":"120","author":"R Assaly","year":"2001","unstructured":"Assaly R et al (2001) Initial evidence of endothelial cell apoptosis as a mechanism of systemic capillary leak syndrome. Chest 120:1301\u20131308","journal-title":"Chest"},{"issue":"3 Suppl 54","key":"3530_CR68","first-page":"26","volume":"27","author":"Y Muro","year":"2009","unstructured":"Muro Y et al (2009) An evaluation of the efficacy of the toe brachial index measuring vascular involvement in systemic sclerosis and other connective tissue diseases. Clin Exp Rheumatol 27(3 Suppl 54):26\u201331","journal-title":"Clin Exp Rheumatol"},{"key":"3530_CR69","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","volume":"43","author":"R Sgonc","year":"2000","unstructured":"Sgonc R et al (2000) Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum 43:2550\u20132562","journal-title":"Arthritis Rheum"},{"key":"3530_CR70","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Codina A, Sime\u00f3n-Aznar CP, Pinal-Fernandez I, Rodr\u00edguez-Palomares J, Pizzi MN, Hidalgo CE (2015) Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival. Rheumatol Int 2015 Oct 25 [Epub ahead of print]","DOI":"10.1007\/s00296-015-3382-2"},{"key":"3530_CR71","first-page":"26","volume":"41","author":"L Muresan","year":"2016","unstructured":"Muresan L, Petcu A, Pamfil C, Muresan C, Rinzis M, Mada RO (2016) Cardiovascular profiles of scleroderma patients arrhythmias and conduction disorders. Acta Reumatol Port 41:26\u201339","journal-title":"Acta Reumatol Port"},{"key":"3530_CR72","first-page":"8","volume":"3","author":"F Cannarile","year":"2015","unstructured":"Cannarile F, Valentini V, Mirabelli G, Alunno A, Terenzi R, Luccioli F (2015) Cardiovascular disease in systemic sclerosis. Ann Transl Med 3:8","journal-title":"Ann Transl Med"},{"key":"3530_CR73","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1054\/jcaf.2003.51","volume":"9","author":"F Fernandes","year":"2003","unstructured":"Fernandes F et al (2003) Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail 9:311\u2013317","journal-title":"J Card Fail"},{"key":"3530_CR74","first-page":"135","volume":"16","author":"J Lekakis","year":"1997","unstructured":"Lekakis J, Mavrikakis M, Emmanuel M, Prassopoulos V, Papazoglou S, Papamichael C et al (1997) Cold-induced coronary Raynaud\u2019s phenomenon in patients with systemic sclerosis. Clin Exp Rheumatol 16:135\u2013140","journal-title":"Clin Exp Rheumatol"},{"key":"3530_CR75","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(89)92088-6","volume":"334","author":"R Gustafsson","year":"1989","unstructured":"Gustafsson R, Kazzam E, Mannting F, Waldenstr\u00f6m A, H\u00e4llgren R (1989) Cold-induced reversible myocardial ischaemia in systemic sclerosis. The Lancet 334:475\u2013479","journal-title":"The Lancet"},{"key":"3530_CR76","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/rheumatology\/25.2.158","volume":"25","author":"A Long","year":"1986","unstructured":"Long A, Duffy G, Bresnihan B (1986) Reversible myocardial perfusion defects during cold challenge in scleroderma. Rheumatology 25:158\u2013161","journal-title":"Rheumatology"},{"key":"3530_CR77","doi-asserted-by":"crossref","first-page":"e0126707","DOI":"10.1371\/journal.pone.0126707","volume":"10","author":"KA Mueller","year":"2015","unstructured":"Mueller KA, Mueller II, Eppler D, Zuern CS, Seizer P, Kramer U (2015) Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy. PLoS ONE 10:e0126707","journal-title":"PLoS ONE"},{"key":"3530_CR78","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/art.1780280607","volume":"28","author":"A Kahan","year":"1985","unstructured":"Kahan A, Nitenberg A, Foult JM, Amor B, Menkes CJ, Devaux JY et al (1985) Decreased coronary reserve in primary scleroderma myocardial disease. Arthritis Rheum 28:637\u2013646","journal-title":"Arthritis Rheum"},{"key":"3530_CR79","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM198401193100302","volume":"310","author":"WP Follansbee","year":"1984","unstructured":"Follansbee WP, Curtiss EI, Medsger TA Jr, Steen VD, Uretsky BF, Owens GR (1984) Rodnan GP (1984) Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. NEJM 310:142\u2013148","journal-title":"NEJM"},{"key":"3530_CR80","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/BOR.0b013e32834b8975","volume":"23","author":"CS Desai","year":"2011","unstructured":"Desai CS, Lee DC, Shah SJ (2011) Systemic sclerosis and the heart: current diagnosis and management. Curr Opin Rheumatol 23:545\u2013554","journal-title":"Curr Opin Rheumatol"},{"key":"3530_CR81","first-page":"36","volume":"1","author":"I Can","year":"2009","unstructured":"Can I, Onat AM, Aytemir K, Akdogan A, Ureten K, Kiraz S et al (2009) Detecting subclinical biventricular impairment in scleroderma patients by use of pulsed-wave tissue Doppler imaging. Tex Heart Inst J 1:36","journal-title":"Tex Heart Inst J"},{"key":"3530_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-7120-8-3","volume":"8","author":"S Schattke","year":"2010","unstructured":"Schattke S, Knebel F, Grohmann A, Dreger H, Kmezik F, Riemekasten G et al (2010) Early right ventricular systolic dysfunction in patients with systemic sclerosis without pulmonary hypertension: a Doppler Tissue and Speckle Tracking echocardiography study. Cardiovasc Ultrasound 8:1","journal-title":"Cardiovasc Ultrasound"},{"key":"3530_CR83","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3899\/jrheum.090931","volume":"37","author":"T Dimitroulas","year":"2010","unstructured":"Dimitroulas T, Giannakoulas G, Papadopoulou K, Karvounis H, Dimitroula H, Koliakos G et al (2010) Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction. J Rheumatol 37:993\u2013999","journal-title":"J Rheumatol"},{"key":"3530_CR84","first-page":"111","volume":"4","author":"S Mavrogeni","year":"2015","unstructured":"Mavrogeni S, Sfikakis PP, Dimitroulas T, Koutsogeorgopoulou L, Karabela G, Katsifis G et al (2015) Imaging patterns of cardiovascular involvement in mixed connective tissue disease evaluated by cardiovascular magnetic resonance. Inflamm Allergy Drug Targets 4:111\u2013116","journal-title":"Inflamm Allergy Drug Targets"},{"key":"3530_CR85","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ehjci\/jeu167","volume":"16","author":"A Barison","year":"2015","unstructured":"Barison A et al (2015) Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging 16:74\u201380","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"3530_CR86","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1532-429X-16-21","volume":"16","author":"NA Ntusi","year":"2014","unstructured":"Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Rai AB, Matthews PM et al (2014) Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis\u2014a clinical study using myocardial T1-mapping and extracellular volume quantification. J Cardiovasc Magn Reson 16:21","journal-title":"J Cardiovasc Magn Reson"},{"key":"3530_CR87","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1871528114666150916112551","volume":"14","author":"S Mavrogeni","year":"2015","unstructured":"Mavrogeni S, Bratis K, Karabela G et al (2015) Cardiovascular Magnetic Resonance Imaging clarifies cardiac pathophysiology in early, asymptomatic diffuse systemic sclerosis. Inflamm Allergy Drug Targets 14:29\u201336","journal-title":"Inflamm Allergy Drug Targets"},{"key":"3530_CR88","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2016.04.158","volume":"217","author":"SI Mavrogeni","year":"2016","unstructured":"Mavrogeni SI, Kitas GD, Dimitroulas T, Sfikakis PP, Seo P, Gabriel S et al (2016) Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use. Int J Cardiol 217:135\u2013148","journal-title":"Int J Cardiol"},{"key":"3530_CR89","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","volume":"52","author":"E Hachulla","year":"2005","unstructured":"Hachulla E, Gressin V, Guillevin L et al (2005) Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 52:3792\u20133800","journal-title":"Arthritis Rheum"},{"key":"3530_CR90","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/rheumatology\/ken179","volume":"47","author":"N Hunzelmann","year":"2008","unstructured":"Hunzelmann N, Genth E, Krieg T et al (2008) The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) 47:1185\u20131192","journal-title":"Rheumatology (Oxford)"},{"key":"3530_CR91","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3899\/jrheum.100245","volume":"37","author":"J Avouac","year":"2010","unstructured":"Avouac J, Air\u00f2 P, Meune C et al (2010) Prevalence of pulmonary hyper- tension in systemic sclerosis in European Caucasians and metaana- lysis of 5 studies. J Rheumatol 37:2290\u20132298","journal-title":"J Rheumatol"},{"key":"3530_CR92","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1445-5994.2008.01823.x","volume":"39","author":"S Phung","year":"2009","unstructured":"Phung S, Strange G, Chung LP et al (2009) Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis. Intern Med J 39:682\u2013691","journal-title":"Intern Med J"},{"key":"3530_CR93","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jcmg.2008.08.007","volume":"2","author":"J Sanz","year":"2009","unstructured":"Sanz J, Kariisa M, Dellegrottaglie S, Prat-Gonzalez S, Garcia MJ, Fuster V, Rajagopalan S (2009) Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. J Am Coll Cardiol Img 2:286\u2013295","journal-title":"J Am Coll Cardiol Img"},{"key":"3530_CR94","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/art.22069","volume":"54","author":"MR Fisher","year":"2006","unstructured":"Fisher MR, Mathai SC, Champion HC et al (2006) Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum 54:3043\u20133050","journal-title":"Arthritis Rheum"},{"key":"3530_CR95","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s10067-010-1494-3","volume":"29","author":"T Dimitroulas","year":"2010","unstructured":"Dimitroulas T, Giannakoulas G, Papadopoulou K et al (2010) Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis. Clin Rheumatol 29:957\u2013964","journal-title":"Clin Rheumatol"},{"key":"3530_CR96","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ahj.2006.09.008","volume":"153","author":"J Tongers","year":"2007","unstructured":"Tongers J, Schwerdtfeger B, Klein G et al (2007) Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart J 153:127\u2013132","journal-title":"Am Heart J"},{"key":"3530_CR97","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1183\/09031936.00074309","volume":"35","author":"SC Mathai","year":"2010","unstructured":"Mathai SC, Bueso M, Hummers LK et al (2010) Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension. Eur Respir J 35:95\u2013104","journal-title":"Eur Respir J"},{"key":"3530_CR98","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/ard.2008.103382","volume":"69","author":"Y Allanore","year":"2010","unstructured":"Allanore Y, Meune C, Vonk MC et al (2010) Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of systemic sclerosis patients. Ann Rheum Dis 69:218\u2013221","journal-title":"Ann Rheum Dis"},{"key":"3530_CR99","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.ijir.3901513","volume":"19","author":"A Aversa","year":"2007","unstructured":"Aversa A, Greco E, Bruzziches R, Pili M, Rosano G, Spera G (2007) Relation-ship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int J Impot Res 19:200\u2013207","journal-title":"Int J Impot Res"},{"key":"3530_CR100","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2013.01.031","volume":"60","author":"S Koka","year":"2013","unstructured":"Koka S, Das A, Salloum FN, Kukreja RC (2013) Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia\/reperfusion injury in type 2 diabetic mice. Free Radic Biol Med 60:80\u201388","journal-title":"Free Radic Biol Med"},{"key":"3530_CR101","doi-asserted-by":"crossref","first-page":"e45243","DOI":"10.1371\/journal.pone.0045243","volume":"7","author":"A Varma","year":"2012","unstructured":"Varma A, Das A, Hoke NN, Durrant DE, Salloum FN, Kukreja RC (2012) Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice. PLoS One7:e45243","journal-title":"PLoS One"},{"key":"3530_CR102","first-page":"54","volume":"26","author":"G Metsios","year":"2015","unstructured":"Metsios G, Lahart IM (2015) Exercise as medicine in rheumatoid arthritis. Mediterr J Rheumatol 26:54\u201361","journal-title":"Mediterr J Rheumatol"},{"key":"3530_CR103","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/rheumatology\/ker191","volume":"50","author":"H John","year":"2011","unstructured":"John H, Carroll D, Kitas GD (2011) Cardiovascular education for people with rheumatoid arthritis: what can existing patient education programmes teach us? Rheumatology (Oxford) 50:1751\u20131759","journal-title":"Rheumatology (Oxford)"},{"key":"3530_CR104","unstructured":"Domsic RT, Dezfulian C, Shoushtari A, Ivanco D, Kenny E, Kwoh CK et al (2014) Endothelial dysfunction is present only in the microvasculature and microcirculation of early diffuse systemics clerosis patients. Clin Exp Rheumatol 32(6 Suppl 86):S-154-60"},{"issue":"65","key":"3530_CR105","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/acr.21819","volume":"2013","author":"M Turiel","year":"2013","unstructured":"Turiel M, Gianturco L, Ricci C, Sarzi-Puttini P, Tomasoni L, Colonna Vde G et al (2013) Silent\u00a0cardiovascular\u00a0involvement\u00a0in\u00a0patients\u00a0with\u00a0diffuse\u00a0systemic\u00a0sclerosis: a\u00a0controlled\u00a0cross-sectional\u00a0study. Arthritis Care Res (Hoboken) 2013(65):274\u2013280","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3530-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-016-3530-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3530-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3530-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T14:15:32Z","timestamp":1498313732000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-016-3530-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,12]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["3530"],"URL":"https:\/\/doi.org\/10.1007\/s00296-016-3530-3","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,12]]}}}